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by F. D. Andrew*6
Most studies designed for assessing teratogenic effects focus on only three offour types of final
manifestations of abnormal development; namely intrauterine death, malformations, and growth
retardation. Developmental toxicity evaluations generally do not include functional deficits.
Current techniques are inadequate for assessing functional capability during perinatal develop-
ment, and there is a need for improved measures. Thus, measurement of developmental enzyme
patterns is proposed as an approach thatdirectly evaluates acquisition ofmetabolic competence of
fundamental organ systems. During ontogenesis most organs acquire their full complement ofen-
zyme activities in a programmed sequence which corresponds to attainment of complete func-
tional capability. The usual alterations in enzyme activity that characterize these patterns occur at
one of three time periods, namely, late fetal, early neonatal, or late suckling. Qualitative or quan-
titative changes in these patterns at any time by one or more key enzymes of a tissue could be in-
dicative ofdevelopmental toxicity. Factors are outlined relating to consideration ofdevelopmental
enzyme profiles as indices of maturation capable of reflecting the action of toxic agents. This
presentation: (1I reviews the current state ofthe art forevaluating effects on development, (2) con-
siders the applicability of enzyme patterns for biochemical assessment of development, 434
characterizes the target tissues and those metabolic pathways and/or specific enzymes most sen-
sitive and adaptable to practical toxicity evaluations, and (44 describes the steps being taken to
validate this system. The ultimate objective of this approach is to determine whether alterations in
developmental enzyme profiles will provide a technique with improved capability for assessing
developmental toxicity.
Introduction
There is a growing recognition of a need for
more sensitive and meaningful methods for as-
sessing the adverse effects of chemical agents on
human health in general and on developing in-
dividuals in particular. This presentation will
consider the use of enzyme profiles as indices of
maturation, which, in turn, may reflect the action
of toxic agents. This approach, measurement of
enzyme patterns in developing tissues, directly
evaluates the acquisition of metabolic compe-
tence by fundamental organ systems.
Most studies designed for assessing terato-
genic effects, regardless of the type of agent,
focus on only three of four final manifestations of
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abnormal development; namely, intrauterine or
neonatal death, malformations, and growth retar-
dation (1). For these studies the agents are given
during major organogenesis, thereby producing
exposures of the embryo. Evidence is ac-
cumulating which suggests that late exposure of
the fetus and possibly even neonatal exposures to
some agents may have deleterious developmental
effects. Perinatal mortality is still a very real
problem for infants throughout the world, and
overt symptomology, such as prematurity with
respiratory distress and/or jaundice, is seen
frequently. Other effects may be less obvious.
For instance, minimal brain dysfunction (MBD) in
children may be an example of a subtle
manifestation of a molecular, if not a cellular,
lesion. While a chemically induced animal model
for MBD has been developed in neonatal rats, its
etiology in children is uncertain (2, 3).
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toxicity has been directed toward assessing mor-
phological and cyotogenetic changes and to a
lesser extent, the behavioral aspects. We know
very little regarding effects on biochemical
systems, that is, the effects of agents upon the
process of development after major
organogenesis (1, 4). Unlike the gross structural
manifestations of embryotoxicity, effects at the
molecular level are not readily evident, and may
be revealed only by special tests. A molecular or
biochemical malformation may remain dormant
for a period, then manifest itself later in life as a
functional impariment, such as: behavioral disor-
der, learning disability, infertility, tumor suscep-
tability, or immunological defect. Most organs
during gestation are potential targets for insults
that may produce cellular and/or molecular le-
sions with profound developmental disturbances
for the individual.
Developmental toxicity evaluations generally
do not include these types of functional deficits.
Current techniques are inadequate for assessing
functional capability during the perinatal period,
and there is a need for improved measures (4).
These problems require evaluation by whatever
methods seem most appropriate. One approach is
to focus on age-dependent changes in enzyme ac-
tivity. Developing tissues contain distinctive en-
zyme complements that exhibit dramatic changes
in their activity coinciding with the critical
phases of the perinatal period. Greengard (5) has
recommended that altered enzyme patterns be
considered "biochemical malformations" that
may serve as more subtle, sensitive and reliable
indicators of perinatal dysfunction than ob-
servations of growth and survival rates. To date
there have been few attempts to monitor effects
of chemical agents on enzymes during develop-
ment other than those involved in oxidative drug
metabolism (6, 7). Significant impairment of
neonatal rat liver and brain enzymes have been
reported after irradiation in utero (8-10). Never-
theless, there have been no comprehensive at-
tempts to fully explore and characterize this ap-
proach to developmental toxicity testing.
Several aspects must be considered in outlining
any proposed model for relating alterations in
functional maturation with altered enzyme
profiles. This requirement has been considered as
a series of specific questions that can be an-
swered analytically and experimentally (Table 1).
The first need is to consider the applicability of
tissue enzyme patterns as biochemical indicators
offunctional capability. Second, it is necessary to
Table 1. Specific aims: to find answers to these questions
regarding the proposed system.
Applicability
How are perinatal studies important?
What relevance have they to humans?
What agents alter development?
When do the agents produce their effects?
Characterization
Which tissues are preferentially affected?
Which enzyme pathways are altered?
How should specific enzymes be selected for analysis?
Are qualitative or quantitative effects more important?
Validation: how can this approach be used to:
Askenvironmentally relevant questions?
Design practical test procedures?
Evaluate environmentally related agents?
Predict human health hazards?
characterize the presumptive target tissues and
those pathways, especially their key enzymes,
that are most suitable for practical toxicity
evaluations. Third, the system still requires
validation by initially testing classical physical
and chemical teratogens before attempting to
demonstrate broad applicability by testing
putative agents.
Applicability
The proposed system is based on the hypoth-
esis that chemically induced changes in activity of
perinatal enzyme systems during development
can be detected and can serve as biochemical in-
dicators ofinsultto developing animals.
During mammalian ontogenesis most organs
acquire their full complement of enzyme activi-
ties in a programmed sequence which corre-
sponds to attainment of complete functional
capability (4, 10-13). Marked variations in many
metabolic functions also occur during develop-
ment. These changes are particularly dramatic at
birth, with the abrupt transition from intra-
uterine to extrauterine environment and during
the weaning period, when great variations in
nutrition occur. These can be further divided into
the late fetal, neonatal, and late suckling periods.
A separate cluster of enzymes attains approxi-
mately adult levels of activity during each of
these periods, coinciding with achievement of in-
creased metabolic competence (4, 13).
To date, most perinatal studies involving en-
zyme patterns have used either normal or en-
docrine-modified animals to reveal the nature of
the regulatory factors for gene expression during
ontogenesis (11). Thus, the approach is relatively
new to developmental toxicity evaluations.
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aldrin/dieldrin, DDT, endrin, cadmium, lead,
mercury, zinc, alkyl sulfonates, hexachlorophene,
PCBs, poly(vinyl chloride), TCDD, ethanol,
radionuclides, and in addition, malnutrition.
While malnutrition is not an agent, it is one ofthe
most common causes of perinatal problems (14).
The other items listed represent examples of
pesticides, industrial effluents, solvents, or sur-
factants with potential hazard as developmental
toxicants. Studies on developmental toxicity
historically have involved use of single agents ad-
ministered under controlled conditions.
Generally, the animals used were supplied with
adequate to excess amounts of all essential
nutrients and were maintained in a uniform en-
vironment. The general population does not live
under such ideally controlled conditions. Actual-
ly, those most likely to experience inadvertant
exposures to harmful agents are those most likely
to suffer dietary imbalances, incontrolled drug
usage, endocrine variations, or pathophysiologi-
cal states that would increase their susceptability
to an adverse reaction.
Test systems need to include some of these
potentials for interactions along with usual
procedures to determine their role in modifying
the animal's response (15, 16). Identification of
alterations in response following such exposures
will be helpful in predicting the synergistic or
protective actions of multiple influences with
respect to developmental toxicity.
It has generally been accepted that the
perinatal and neonatal periods are among the
most sensitive stages of life. The lack of ap-
propriate data on the response ofthese immature
stages to exposure to toxic agents has prevented
the full utilization and consideration of tissue en-
zyme ontogenesis as a test system.
Characterization
A number of factors justify the need to charac-
terize developmental enzyme patterns. Of par-
ticular significance is the determination of which
organ(s) represent(s) the major site(s) for ad-
verse effects on maturation during different
stages ofdevelopment.
There is need to consider the distribution of
selected enzymes in organs other than liver, in-
cluding brain, lung, kidney, and intestine.
However, the value of comparative organ studies
will be influenced by the physicochemical proper-
ties of the agent, its probable route of entry, and
its pharmacokinetics. Current studies are at-
tempting to characterize effects on the develop-
mental patterns of several enzymes in various
tissues at different perinatal stages with classical
physical and chemical agents. These types of
studies also need to investigate the most com-
monly occurring and biologically significant path-
ways. Information gained from such studies can
aid in predicting how the conceptus will respond
to certain chemicals and whether this response is
related to fetal disposition oftoxic agents.
Analysis of enzyme patterns during hormonal
or nutritional regulation and the control of gene
expression during differentiation and especially
in neoplastic tissues have been conducted by
Weber et al. (17-19). These studies, led to the
identification of a number of key enzymes in
various intermediary metabolism pathways that
were considered to be the main targets of
metabolic control. Some of the features that
characterize them have recently been discussed
(18, 19). A molecular correlation concept was
developed to provide a means for studying gene
expression at the molecular level and was based
on the assumption that various cellular functions
could be analyzed, correlated and understood in
appropriate terms. Likewise, it is recognized that
for an understanding of the regulation of the
biochemical patterns and their correlation with
appropriate biological characteristics of develop-
ment, experimental efforts must concentrate on
key enzymes and critical metabolic pathways.
Focusing on the key enzymes defined by Weber
(17-19) precludes the necessity of assaying a
larger proportion of the approximately 160 en-
zymes identified in rat liver alone (20). Rather, a
quartet of key gluconeogenic enzymes and a trio
of key glycolytic enzymes may adequately
evaluate effects on carbohydrate metabolism
(21). Similar groups of enzymes operating in
purine, pyrimidine, DNA, ornithine, and cAMP
metabolism have been identified as key enzymes
(21). The ultimate selection of target tissue en-
zymes for testing thus requires consideration of
characteristics of the presumed target tissue as
well as those factors requiring specific
knowledge, such as the probable action ofthe test
agents. Such additional criteria for enzyme selec-
tion are: (1) low levels related to human disor-
ders; (2) easily measured by standard assays; (3)
distributed in more than one tissue; (4) active in
soluble or bound form; (5) stability ofappropriate
preparations; (6) detectable in amniotic fluid.
Primarily, control ofmetabolism in mammals is
achieved through modulation of activity and/or
amount of regulatory enzymes. Thus, a
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which the shift from control activity levels dif-
fered by several orders of magnitude or a tem-
poral deviation of more than one day was seen.
Qualitative changes of note would be shifts in
metabolic pathways from primarily synthetic to
more degradative activity or shifts in isozyme
patterns. Some of these aberrations might be
permanent, but the stage of the conceptus at the
time of exposure would influence the degree of
response. Qualitative or quantitative changes in
the enzyme patterns at any time by one or more
key enzymes of a tissue could be indicative of
developmental toxicity.
These studies should provide information con-
cerning: (a) which organ or organs are most
susceptable to alteration of constituent enzymes
at different ages, (b) what pathways are most
likely to be affected in a particular perinatal
period, and (c) what is the inter- and intralitter
variation in response of offspring to gestational
insult?
Validation
A number offactors are beingconsidered in the
validation of this test system (Table 2). The in-
sults selected for testing include salicylate and
hydroxyurea (two classical chemical teratogens),
Table 2. Factors considered for design ofdevelopmental tox-
icity evaluations.
Selection oftest species
Ontogenic similarities to man
Pharmacokinetics ofagent
Developmental stages for agent administration
Major organogenesis
Late fetalperiod
Early postnatal period
Exposure Parameters
At least three doses ranging from maximum tolerated to
no apparent effect
Routes related toanticipated human exposure and proper-
ties ofagent
Include both nontreated and vehicle controls
Dosage Schedule-Minimum Requirement
More than one developmental stage per dose
Atleast five animals per dose and stage
"Routine teratology" evaluation criteria
Toxicity: maternal weight change
Embryolethality: embryoresorptions and fetal deaths
Malformations: external, visceral, and skeletal
Growth retardation: fetal weight
Postnatal parameters: functional capacity
Growth rate and survival
Behavior andlearning ability
Biochemical and physiological processes
Inmunological determinants
radiation (a classical physical teratogen) and
malnutrition (a common environmental con-
dition). There is experimental evidence that both
chemicals affect postnatal behavior in rats, when
administered under the appropriate conditions
that induce malformations, but given at lower
levels (22, 23). Intrauterine exposure of rats and
beagles to x- or y-radiation has been reported to
alter levels of several enzymes in liver and brain
of neonatal animals (8-10). The potential for
developmental problems following maternal
malnutrition alone or in combination with such
physical and chemical agents was discussed
previously.
Our initial studies will be restricted to rats. As
appropriate, other species may be included for
their variations in degree of maturity ofoffspring
at term and duration of gestation (4, 24). For the
subsequent investigations, pharmacokinetic
studies may be conducted concurrently with en-
zyme studies, depending on the agents selected
for evaluation.
Test agents will be administered to the dam
either during major organogenesis or during the
late fetal period or, possibly, during lactation.
Administration directly to the offspring during
the first 48 hr postnatally will also be con-
sidered for some agents. Radiation will be given
either as a single whole-body exposure or it will
be limited to the exteriorized gravid uterus.
Magnitude and duration of malnutrition will
depend on the dietary components to be deleted,
such as proteins, fats, carbohydrates, minerals,
or vitamins.
A general outline ofthe proposed experimental
design (Table 3) gives the major points regarding
the exposure parameters and dosage schedule.
Generally, dose levels tested will range from
those toxic to the dam to those that appear to be
without effect to the conceptus and will include at
least one intermediate level. These studies will
focus on the more subtle effects on biochemical
and physiological processes that result from ad-
ministration of low doses to immature animals as
compared to adults. Control animals will receive
an equal volume of vehicle or an appropriate
sham procedure on the same gestation days as
the treatments or no exposure. Body weights of
dams will be monitored periodically throughout
gestation. Generally, five to six litters will be in-
cluded in each group.
As indicated in Table 2, "routine teratology"
evaluations will be conducted on representative
litters to correlate morphological events with the
enzyme activity data. These evaluations will in-
clude: counting the implantation sites, noting the
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Gesta- Agent
tional or
Developmental postnatal Salicy- Hydroxy- Radia-
stage day late urea tion
Fertilization 1
Majororgan- 9 EXPb
ogenesis 10 INJ
11
12
13 INJ
Late fetal 18
19 INJ/SAC INJ/SAC EXP/SAC
20 SAC SAC SAC
21 SAC d SAC d SAC d
22 SAC SAC SAC
Postnatal Birth
1 INJ INJ EXP
2
3 SAC SAC SAC
4 SAC SAC SAC
5 SAC SAC SAC
6 SAC SAC SAC
7 SAC SAC SAC
Preweaning 18 SAC SAC SAC
19 SAC SAC SAC
20 SAC SAC SAC
21 SAC SAC SAC
22 SAC SAC SAC
INJ = Developmental period for agent administration at
appropriate dosage levels.
EXP = Developmental period for exposure to x or
y-irradiation.
c SAC = Developmental periods for enzyme analysis and/or
measurement ofother parameters.
d"Routine" teratology evaluations are performed on
representative animals at gestation day 21.
general condition and viability of each conceptus,
recording sex and weight for each live fetus,
examining each pup for external malformations,
and processing representative pups of each litter
to detect visceral and/or skeletal alterations.
All enzyme measurements will be made by
using standard procedures whenever possible,
but modifications of some procedures may be
needed. All enzyme assay methods will be
verified under optimal conditions using purified
enzymes, if commercially available. Generally,
four to five consecutive ages of animals will be
analyzed at each cluster. Thus, sudden fluc-
tuations in enzyme activity can be detected and
activity differences can be monitored throughout
specific test periods.
There are a number ofconceptual and technical
errors that could lead to a lack of correlation bet-
ween biochemical malformations and metabolic
dysfunction: (a) marked changes in indicators of
biochemical function may occur without affecting
functional reserve capacity; (b) significant
changes in enzyme activity may reflect reversible
functional effects without permanent sequela,: (c)
altered enzyme activity may reflect a generalized
response to stress and not a specific response to
the toxic agent; (d) marked species variations in
enzymatic alterations may occur in response to a
specific insult, especially if there are species dif-
ferences in pharmacokinetics; (e) permanent ef-
fects on enzymes may depend on a specific time
for the insult.
Thus, the effect of relevant gestational insults
on perinatal enzyme patterns will be studied in
reference to the following specific objectives.
Developmental profiles of certain key enzymes
will be traced in hepatic and some extrahepatic
tissues at various time periods. Changes in en-
zyme activity profiles will be correlated with
other functional indicators. Enzyme activities of
corresponding maternal tissues will be measured
simultaneous with those of their pups at the ap-
propriate times. The importance of altered
profiles to growth rates and survival for times up
to and including sexual maturity will be in-
vestigated.
In summary, the ultimate objective of this ap-
proach is to determine whether alterations in en-
zyme profiles will provide a technique with im-
proved capability for assessing developmental
toxicity.
In October 1975, National Institute of Environmental Health
Sciences (NIEHS) sponsored a conference entitled, "Enzyme
Patterns in the Evalution of Developmental Toxicity" at the
Research Triangle Park, N.C. The informative comments, ob-
servations, and discussions of the invited speakers and other
participants were helpful in formulating my ideas. However,
the statements given in this presentation are my own opinions,
biases, and prejudices and are not intended to reflect those of
the workshop participants. Special thanks go to Dr. Robert L.
Dixon and other staff members at NIEHS for their contribu-
tions to the success ofthe workshop.
In addition to NIEHS staff scientists, participants included:
K. P. Chepenik, M. Feigelson, 0. Greengard, R. W. Hanson, S.
Harris, A. Herzfeld, E. M. Johnson, E. Kun, J. Murray, B. A.
Schwetz, W. J. Scott, B. R. Sonawane, K. Taketa, J. B. War-
shaw, and G. Weber.
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